Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,107 public trials 2,039 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

NCT03859427

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Bone Marrow Neoplasms, +21 more
Locations
  • Robert A Moss Oncology Fountain Valley, California, United States
  • Rocky Mountain Cancer Centers Denver Midtown Denver, Colorado, United States
  • Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut Plainville, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
View all 108 locations
View Trial Details
Completed

A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia

NCT05326516

Conditions
Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, +17 more
Locations
  • University of California, San Francisco (UCSF) Benioff Children's Hospital San Francisco, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Children's Mercy Hospital Kansas City, Missouri, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Efficacy and Safety of Tenalisib (RP6530) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

NCT04204057

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • University Multiprofile Hospital for Active Treatment "Dr Georgi Stranski" Ltd., Pleven, Bulgaria
  • University Multiprofile Hospital for Active Treatment "Sv Ivan Rilski" Ltd Sofia, Bulgaria
  • Ltd. M.Zodelava Hematology Centre Tbilisi, Georgia
  • Medivest - Institute of Hematology and Transfusiology Tbilisi, Georgia
View Trial Details
Completed

A Study of Chinese Adults With Lymphoma

NCT05288491

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
View all 19 locations
View Trial Details
Completed

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

NCT02595866

Conditions
AIDS-Related Non-Hodgkin Lymphoma, Adenocarcinoma, Blood-Borne Infections, +76 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Zuckerberg San Francisco General Hospital San Francisco, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
View Trial Details

Related conditions